Defunct Company
Total Trials
17
As Lead Sponsor
7
As Collaborator
10
Total Enrollment
4,686
NCT00002689
Radiation Therapy Plus Chemotherapy in Treating Patients With Pancreatic Cancer
Phase: Phase 2
Role: Lead Sponsor
Start: Sep 30, 1995
Completion: Jun 30, 2007
NCT00004129
Phosphorus 32 in Treating Patients With Glioblastoma Multiforme
Phase: Phase 1
Start: Sep 30, 1999
Completion: Not specified
NCT00005939
Brachytherapy in Treating Patients With Recurrent Prostate Cancer
Phase: Phase 1/2
Start: Nov 30, 1999
NCT00006212
Phosphorus-32 Plus Radiation Therapy and Chemotherapy in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer
NCT02017340
A Phase III Trial of Nilvadipine to Treat Alzheimer's Disease
Phase: Phase 3
Role: Collaborator
Start: Apr 24, 2013
Completion: Dec 16, 2016
NCT03973203
Niacin Supplementation in Healthy Controls and Mitochondrial Myopathy Patients
Phase: N/A
Start: Jun 1, 2014
Completion: Dec 31, 2018
NCT02444598
Trial of Negative-pressure Wound Therapy Use in Conflict-related Extremity Wounds
Start: Jun 30, 2015
Completion: Jan 31, 2019
NCT02519582
Drug Trial to Investigate the Safety and Efficacy of Niclosamide Tablets in Patients With Metastases of a Colorectal Cancer Progressing After Therapy
Start: Aug 31, 2015
Completion: Aug 31, 2020
NCT03288389
Membrane Lipid Replacement in Fibromyalgia
Start: May 1, 2017
Completion: Jun 1, 2023
NCT03650127
Returning Genome and Metabolome Data to FinTerveys 2017 Participants: P5.fi FinTerveys Study
Start: Feb 2, 2018
Completion: Dec 31, 2023
NCT03829176
Investigating the Feasibility and Implementation of Whole Genome Sequencing in Patients With Suspected Genetic Disorder
Start: Mar 1, 2018
Completion: Oct 1, 2020
NCT04538521
NiaMIT Continuation With Early-stage Mitochondrial Myopathy Patients
Start: Feb 11, 2019
Completion: Sep 18, 2020
NCT04037150
Circulating DNA in Surgically Treated NSCLC
Start: Jul 1, 2019
Completion: Dec 31, 2020
NCT05642429
Study of AV-1959D, an Amyloid Beta Vaccine
Start: Feb 27, 2023
Completion: Nov 7, 2026
NCT05043701
Individualized Systems Medicine Functional Profiling for Recurrent Glioblastoma
Phase: Early Phase 1
Start: Mar 1, 2023
Completion: Feb 28, 2026
NCT07142278
DUVAX: A Phase 1 Alzheimer's Vaccine Study Targeting Amyloid-Beta and Tau
Start: Nov 1, 2025
Completion: Jul 31, 2027
NCT07158905
AV-1980R (Tau Vaccine) in Preclinical Alzheimer's Disease (TAURUS-1980)
Start: Dec 15, 2025
Completion: Oct 15, 2029